From Tools to Trials: Editing Therapy Companies Pivot to Development
Genetic Engineering & Biotechnology News
|
March 20, 2025
X min read
Genetic Engineering & Biotechnology News
|
March 20, 2025
Share on Social
More like this
Media
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
July 27, 2026
Read Now
Press
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
July 27, 2026
Read Now
